Carl H. June
- Immunology top 0.01%
- Immune Cell Function and Interaction 217
- T-cell and B-cell Immunology 143
- Immunotherapy and Immune Responses 132
- Oncology top 0.01%
- CAR-T cell therapy research 381
- Genetics top 0.01%
- Virus-based gene therapy research 117
- Virology top 0.1%
- HIV Research and Treatment 42
- Hematology top 0.1%
-
- Viral Infectious Diseases and Gene Expression in Insects 57
- CRISPR and Genetic Engineering 56
- Co-authors
- Bruce L. LevineDavid L. PorterMichael KalosJames L. RileyStephan A. GruppCraig B. ThompsonMichael C. MiloneDavid C. Fajgenbaum
- Cited by
- ImmunologyOncologyGenetics
- Partner nations
- United StatesSwitzerlandGermany
In The Last Decade
Carl H. June
645 papers receiving 84.1k citations
Hit Papers
Peers
Comparison fields: 5 of 182
- Immunology 40.7k
- Oncology 52.4k
- Genetics 16.4k
- Virology 2.7k
- Hematology 4.7k
Countries citing papers authored by Carl H. June
This map shows the geographic impact of Carl H. June's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carl H. June with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carl H. June more than expected).
Fields of papers citing papers by Carl H. June
This network shows the impact of papers produced by Carl H. June. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carl H. June. The network helps show where Carl H. June may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Carl H. June, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 39 | |
| 2 | 2022 | 34 | |
| 3 | 2021 | 23 | |
| 4 | 2020 | 155 | |
| 5 | 2018 | 204 | |
| 6 | 2017 | 153 | |
| 7 | A Chimeric Switch-Receptor Targeting PD1 Augments the Efficacy of Second-Generation CAR T Cells in Advanced Solid Tumorsbreakdown → | 2016 | 420 |
| 8 | 2016 | 141 | |
| 9 | 2015 | 303 | |
| 10 | 2015 | 48 | |
| 11 | 2014 | 65 | |
| 12 | 2013 | 106 | |
| 13 | 2013 | 285 | |
| 14 | Mesothelin-Specific Chimeric Antigen Receptor mRNA-Engineered T Cells Induce Antitumor Activity in Solid Malignanciesbreakdown → | 2013 | 693 |
| 15 | Expression of a Functional CCR2 Receptor Enhances Tumor Localization and Tumor Eradication by Retargeted Human T cells Expressing a Mesothelin-Specific Chimeric Antibody Receptorbreakdown → | 2011 | 447 |
| 16 | 2011 | 12 | |
| 17 | 2011 | 237 | |
| 18 | 2010 | 366 | |
| 19 | 2010 | 230 | |
| 20 | Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kineticsbreakdown → | 2010 | 805 |
About Carl H. June
Carl H. June is a scholar working on Immunology, Oncology and Virology, having authored 657 papers that have together received 85.8k indexed citations. Recurring topics across this work include CAR-T cell therapy research (381 papers), Immune Cell Function and Interaction (217 papers), T-cell and B-cell Immunology (143 papers), Immunotherapy and Immune Responses (132 papers), Virus-based gene therapy research (117 papers), Viral Infectious Diseases and Gene Expression in Insects (57 papers), CRISPR and Genetic Engineering (56 papers) and HIV Research and Treatment (42 papers). The work is most often cited by research in Immunology (40.7k citations), Oncology (52.4k citations) and Genetics (16.4k citations). Carl H. June has collaborated with scholars based in United States, Switzerland and Germany. Frequent co-authors include Bruce L. Levine, David L. Porter, Michael Kalos, James L. Riley, Stephan A. Grupp, Craig B. Thompson, Michael C. Milone, David C. Fajgenbaum, Adam Bagg and Michel Sadelain. Their work appears in journals such as Nature, Science and New England Journal of Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.